Michael Shipley

2.9k citations
24 papers · 2.3k indexed · 1 hit paper · h-index 14

Michael Shipley

23 papers receiving 2.1k citations

Hit Papers

Leukotriene B, a potent chemokinetic and aggregating subs...1.7k198020261995201050010001.5k

Peers

Michael Shipley
Comparison fields: 5 of 117
  • Immunology and Allergy 244
  • Biochemistry 231
  • Immunology 645
  • Pharmacology 493
  • Physiology 723
Replace J Björk with:
J Björk Sweden
M. M. Monick United States
Adrian Moore United Kingdom
Anthony P. Sampson United Kingdom
Marc E. Goldyne United States
Kottarappat N. Dileepan United States
Eric S. Silverman United States
Gordon Dent United Kingdom
Nicholas A. Pawlowski United States
Yukio Ishii Japan
Michael Shipley relative to J Björk Sweden J Björk's profile →
Citations per field
00.5×1.5×2.0×
J Björk · 1×
Citations per year

Countries citing papers authored by Michael Shipley

Since Specialization
Citations

This map shows the geographic impact of Michael Shipley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Shipley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Shipley more than expected).

Fields of papers citing papers by Michael Shipley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Shipley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Shipley. The network helps show where Michael Shipley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Shipley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Shipley Line = papers co-authored together Michael Shipley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201111
2 200839
3
Pain : best practice & research compendium
20073
4 20050
5 199738
6 19948
7 1993103
8 19923
9 199018
10 199010
11 198826
12 198818
13
HLA frequency and haplotype analysis in a family study of adult onset rheumatoid arthritis.
19862
14 198615
15 198649
16 198365
17 198013
18 198045
19 19807
20 197312

About Michael Shipley

Michael Shipley is a scholar working on Rheumatology, Immunology, Anesthesiology and Pain Medicine, Pharmacology and Rehabilitation, having authored 24 papers that have together received 2.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Spondyloarthritis Studies and Treatments (2 papers), Immune Cell Function and Interaction (2 papers), Musculoskeletal pain and rehabilitation (2 papers), Immune Response and Inflammation (2 papers) and Musculoskeletal Disorders and Rehabilitation (2 papers). The work is most often cited by research in Immunology and Allergy (244 citations), Biochemistry (231 citations), Immunology (645 citations), Pharmacology (493 citations) and Physiology (723 citations). Michael Shipley has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include M. J. H. Smith, M.A. Bray, A. W. Ford‐Hutchinson, Mira Doig, Alan J. Silman, M Corbett, Amanda Young, Seamus E. Dalton, A. B. Kurtz and Fiona Cunningham. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, The Lancet, Journal of Pharmacy and Pharmacology and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026